scPharmaceuticals Inc [SCPH] stock is trading at $3.52, up 9.32%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The SCPH shares have gain 41.94% over the last week, with a monthly amount glided 36.96%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
scPharmaceuticals Inc [NASDAQ: SCPH] stock has seen the most recent analyst activity on September 07, 2023, when Craig Hallum initiated its Buy rating and assigned the stock a price target of $20. Previously, Cowen started tracking the stock with Outperform rating on December 01, 2022, and set its price target to $25. SVB Leerink upgraded its rating to a Outperform but stick to its price target of $11 on October 11, 2022. Maxim Group initiated its recommendation with a Buy and recommended $10 as its price target on August 02, 2022. SVB Leerink started tracking with a Mkt Perform rating for this stock on September 09, 2021, and assigned it a price target of $6. In a note dated October 15, 2019, H.C. Wainwright initiated an Buy rating and provided a target price of $13 on this stock.
scPharmaceuticals Inc [SCPH] stock has fluctuated between $1.94 and $5.65 over the past year. Currently, Wall Street analysts expect the stock to reach $13 within the next 12 months. scPharmaceuticals Inc [NASDAQ: SCPH] shares were valued at $3.52 at the most recent close of the market. An investor can expect a potential return of 269.32% based on the average SCPH price forecast.
Analyzing the SCPH fundamentals
scPharmaceuticals Inc [NASDAQ:SCPH] reported sales of 41.98M for the trailing twelve months, which represents a growth of 92.59%. Gross Profit Margin for this corporation currently stands at 0.69% with Operating Profit Margin at -1.59%, Pretax Profit Margin comes in at -2.16%, and Net Profit Margin reading is -2.16%. To continue investigating profitability, this company’s Return on Assets is posted at -1.0, Equity is -7.54 and Total Capital is -0.89. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -10.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, scPharmaceuticals Inc’s Current Ratio is 5.48. In addition, the Quick Ratio stands at 4.61 and the Cash Ratio stands at 3.53. Considering the valuation of this stock, the price to sales ratio is 4.43.
Transactions by insiders
Recent insider trading involved ORBIMED ADVISORS LLC, 10% Owner, that happened on Aug 13 ’24 when 0.5 million shares were purchased.
